SE0300117D0 - Novel Compounds - Google Patents

Novel Compounds

Info

Publication number
SE0300117D0
SE0300117D0 SE0300117A SE0300117A SE0300117D0 SE 0300117 D0 SE0300117 D0 SE 0300117D0 SE 0300117 A SE0300117 A SE 0300117A SE 0300117 A SE0300117 A SE 0300117A SE 0300117 D0 SE0300117 D0 SE 0300117D0
Authority
SE
Sweden
Prior art keywords
novel compounds
formula
compounds
thienopyridazinones
therapy
Prior art date
Application number
SE0300117A
Other languages
Swedish (sv)
Inventor
Simon Guile
Tony Ingall
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0300117A priority Critical patent/SE0300117D0/en
Publication of SE0300117D0 publication Critical patent/SE0300117D0/en
Priority to CNB2004800024049A priority patent/CN100354282C/en
Priority to BR0406782-7A priority patent/BRPI0406782A/en
Priority to PCT/SE2004/000053 priority patent/WO2004065395A1/en
Priority to JP2006500751A priority patent/JP2006515880A/en
Priority to CA002512136A priority patent/CA2512136A1/en
Priority to RU2005121492/04A priority patent/RU2332420C2/en
Priority to NZ541218A priority patent/NZ541218A/en
Priority to EP04702470A priority patent/EP1587811A1/en
Priority to PL378221A priority patent/PL378221A1/en
Priority to AU2004206011A priority patent/AU2004206011B2/en
Priority to KR1020057013127A priority patent/KR20050092761A/en
Priority to UAA200506373A priority patent/UA82497C2/en
Priority to MXPA05007495A priority patent/MXPA05007495A/en
Priority to US10/542,457 priority patent/US7393854B2/en
Priority to IL169369A priority patent/IL169369A0/en
Priority to ZA200505227A priority patent/ZA200505227B/en
Priority to IS7962A priority patent/IS7962A/en
Priority to NO20053825A priority patent/NO20053825L/en
Priority to US12/124,319 priority patent/US20080221131A1/en

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to thienopyridazinones compound of formula (I) wherein: R1, R2 and Q are as defined in the specification, and Ar and Ar2 are selected from certain aromatic ring systems, which may be optionally substituted, as defined in the specification. Processes for the preparation of compounds of formula (I), pharmaceutical compositions containing them and their use in therapy is also described and claimed.
SE0300117A 2003-01-17 2003-01-17 Novel Compounds SE0300117D0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
SE0300117A SE0300117D0 (en) 2003-01-17 2003-01-17 Novel Compounds
US10/542,457 US7393854B2 (en) 2003-01-17 2004-01-15 Thienopyrimidinedinones and their use in modulation of autoimmune disease
EP04702470A EP1587811A1 (en) 2003-01-17 2004-01-15 Thienopyridazinones and their use in modulation of autoimmune disease
AU2004206011A AU2004206011B2 (en) 2003-01-17 2004-01-15 Thienopyridazinones and their use in modulation of autoimmune disease
PCT/SE2004/000053 WO2004065395A1 (en) 2003-01-17 2004-01-15 Thienopyridazinones and their use in modulation of autoimmune disease
JP2006500751A JP2006515880A (en) 2003-01-17 2004-01-15 Thienopyridazinone and its use in the regulation of autoimmune diseases
CA002512136A CA2512136A1 (en) 2003-01-17 2004-01-15 Thienopyridazinones and their use in modulation of autoimmune disease
RU2005121492/04A RU2332420C2 (en) 2003-01-17 2004-01-15 Thienopyrimidindions and their application in autoimmune disease modulation
NZ541218A NZ541218A (en) 2003-01-17 2004-01-15 Thienopyrimidinediones and their use in modulation of autoimmune disease
CNB2004800024049A CN100354282C (en) 2003-01-17 2004-01-15 Thienopyridazinones and their use in modulation of autoimmune disease
PL378221A PL378221A1 (en) 2003-01-17 2004-01-15 Thienopyridazinones and their use in modulation of autoimmune disease
BR0406782-7A BRPI0406782A (en) 2003-01-17 2004-01-15 Thieno-pyridazinone derivatives and their use in modulating autoimmune diseases
KR1020057013127A KR20050092761A (en) 2003-01-17 2004-01-15 Thienopyridazinones and their use in modulation of autoimmune disease
UAA200506373A UA82497C2 (en) 2003-01-17 2004-01-15 thienopyridazinones and theair use
MXPA05007495A MXPA05007495A (en) 2003-01-17 2004-01-15 Thienopyridazinones and their use in modulation of autoimmune disease.
IL169369A IL169369A0 (en) 2003-01-17 2005-06-23 Thienopyridazinones and their use in modulation of autoimmune disease
ZA200505227A ZA200505227B (en) 2003-01-17 2005-06-28 Thienopyridazinones and their use in modulation of autoimmune disease
IS7962A IS7962A (en) 2003-01-17 2005-07-27 Thienopyridazinone and its use in the modification of autoimmune disease
NO20053825A NO20053825L (en) 2003-01-17 2005-08-15 Thienopyridazinones and their use in modulating autoimmune diseases.
US12/124,319 US20080221131A1 (en) 2003-01-17 2008-05-21 Thienopyrimidinediones and their use in modulation of autoimmune disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0300117A SE0300117D0 (en) 2003-01-17 2003-01-17 Novel Compounds

Publications (1)

Publication Number Publication Date
SE0300117D0 true SE0300117D0 (en) 2003-01-17

Family

ID=20290152

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0300117A SE0300117D0 (en) 2003-01-17 2003-01-17 Novel Compounds

Country Status (4)

Country Link
CN (1) CN100354282C (en)
SE (1) SE0300117D0 (en)
UA (1) UA82497C2 (en)
ZA (1) ZA200505227B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702001D0 (en) * 1997-05-28 1997-05-28 Astra Pharma Prod Novel compounds

Also Published As

Publication number Publication date
UA82497C2 (en) 2008-04-25
CN1738825A (en) 2006-02-22
CN100354282C (en) 2007-12-12
ZA200505227B (en) 2006-11-29

Similar Documents

Publication Publication Date Title
ATE433447T1 (en) PYRIMIIDINE COMPOUNDS
SE0300119D0 (en) Novel compounds
NO20070224L (en) 2-urea-4-phenylthiazole derivatives, preparation and therapeutic use thereof
SE0301700D0 (en) Novel compounds
SE0202133D0 (en) Novel compounds
SE0200920D0 (en) Novel compounds
EA200500312A1 (en) NEW SPIROCONDENSED HINASOLINONES AND THEIR APPLICATION AS PHOSPHODYESTERES INHIBITORS
MXPA05012025A (en) Imidazo and thiazolopyridines as jak3 kinase inhibitors.
TW200621262A (en) New dihydropteridione derivatives, process for their manufacture and their use as medicament
BRPI0412659A (en) cci-779 isomer c, its preparation process, pharmaceutical composition comprising the same and pharmaceutical package containing said compound
DE60314623D1 (en) SUBSTITUTED PYRAZOLOPYRIMIDINES
WO2004106293A3 (en) Oxazolyl - and thiazolyl - purine based tricyclic compounds.
SE0302139D0 (en) Novel compounds
ATE332301T1 (en) ANTIVIRAL PYRAZOLOPYRIDINE COMPOUNDS
SE0401762D0 (en) Novel compounds
EA200702375A1 (en) UREA DERIVATIVES, METHODS FOR THEIR RECEPTION AND APPLICATION
SE0303541D0 (en) New compounds
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
PL376324A1 (en) Piperazinyl and diazapanyl benzamides and benzthioamides
SE0300091D0 (en) Novel compounds
DE602004029355D1 (en) SULFOPYRROLDERIVATE
NO20053825L (en) Thienopyridazinones and their use in modulating autoimmune diseases.
WO2005011609A3 (en) Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
SE0303280D0 (en) Novel compounds
WO2004075846A3 (en) Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same